Article

Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) candidate vaccine (1790GAHB).

2023-09-21

Abstract excerpt

<title>Abstract</title> <p><italic>Shigella</italic> spp. are a leading bacterial cause of diarrhea. No widely licensed vaccines are available and there is no generally accepted correlate of protection. We tested a <italic>S. sonnei</italic> Generalized Modules for Membrane Antigen (GMMA)-based vaccine (1790GAHB) in a phase 2b, placebo-controlled, randomized, controlled human infection model study (NCT03527173) e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd9df88e-df86-502b-946c-8b0eadaf3589
DOI: 10.21203/rs.3.rs-3314985/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Towards establishing correlates of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) candidate vaccine (1790GAHB).DOI 10.21203/rs.3.rs-3314985/v1Read

Towards establishing a correlate of protection against shigellosis: assessing immunological endpoints across immune responses to the Shigella sonnei 1790GAHB GMMA investigational vaccineSemantic proximity Read

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to ShigellaSemantic proximity Read

A next-generation GMMA-based vaccine candidate to fight shigellosisSemantic proximity Read

Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against ShigellaSemantic proximity Read

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protectionSemantic proximity Read

Towards a Four-Component GMMA-Based Vaccine against ShigellaSemantic proximity Read

Status of vaccine research and development for ShigellaSemantic proximity Read

The Shigella Vaccines PipelineSemantic proximity Read

Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approachesSemantic proximity Read

Testing S. sonnei GMMA with and without Aluminium Salt-Based Adjuvants in Animal ModelsSemantic proximity Read

Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesSemantic proximity Read

Frontiers in Shigella Vaccine DevelopmentSemantic proximity Read